Universal Health Services is expected to report strong earnings growth in its upcoming quarterly report.

Universal Health Services, Inc. (UHS) is a healthcare company valued at $12 billion, offering a range of services including surgery, internal medicine, and behavioral health. It is expected to announce its fiscal Q2 earnings for 2025 on July 23, with analysts projecting a profit of $4.87 per share, up 13% from the year-ago quarter.

Analysts anticipate UHS to report EPS of $19.43 for the full year, up 17% from fiscal 2024, and expect further growth to $21.16 in fiscal 2026. Although UHS has slightly declined over the past 52 weeks, it has outperformed the Health Care Select Sector SPDR Fund during the same period.

Following its Q1 results release on Apr. 28, UHS saw improved revenue of 6.7% year-over-year to $4.1 billion. Despite falling short of consensus estimates, the company’s adjusted EPS surged 30.8% to $4.84, exceeding analyst expectations by 11%. Wall Street analysts rate UHS as a “Moderate Buy” with a mean price target of $226.19.

Read more at Yahoo Finance: What to Expect From Universal Health Services’ Next Quarterly Earnings Report